| FullText URL | fulltext20230112-4.pdf figures20230112-4.pdf online-supplemental-figures20230112-4.pdf online-supplemental-Tables20230112-4.pdf |
|---|---|
| Author | Matsumoto, Naomi| Hagiya, Hideharu| Nakayama, Masanori| Furukawa, Masanori| Mitsuhashi, Toshiharu| Takao, Soshi| Otsuka, Fumio| Yorifuji, Takashi| |
| Keywords | SARS-CoV-2 Vaccine Antibody Reactogenicity Adverse reaction Mixed-effects model |
| Note | © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. This manuscript version is made available under the CC-BY-NC-ND 4.0 License. http://creativecommons.org/licenses/by-nc-nd/4.0/. This is the accepted manuscript version. The formal published version is available at [https://doi.org/10.1016/j.jiac.2022.09.012] . | This full-text file will be available in Nov. 2023.| |
| Published Date | 2022-11-12 |
| Publication Title | Journal of Infection and Chemotherapy |
| Volume | volume29 |
| Issue | issue1 |
| Publisher | Elsevier BV |
| Start Page | 39 |
| End Page | 42 |
| ISSN | 1341-321X |
| NCID | AA11057978 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases |
| File Version | author |
| PubMed ID | 36168999 |
| DOI | 10.1016/j.jiac.2022.09.012 |
| Web of Science KeyUT | 000894818300007 |
| Related Url | isVersionOf https://doi.org/10.1016/j.jiac.2022.09.012 |
